Analyst Ratings for Regeneron Pharma (regn)

regn Rating Summary

regn Price Target Summary

* Over Last 12-Mos
  |   Expand Research on regn
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $473.69 (+28.4%) * Over Last 12-Mos
Rating Score: 5 / 10   Percentile Rank: 56%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
8/5/2016 Baird
» Updated 11/4/2016
Downgrade Neutral
(Outperform)
379.00
(448.00)
433.40 368.95 -14.87% Details
6/29/2016 Bernstein New Coverage Outperform
(N/A)
400.00
(N/A)
339.78 368.95 8.58% Details
Like REGN Ratings? Also take a look at SNY, SAN, AMGN, CELG

REGN Ratings News